Hostname: page-component-848d4c4894-5nwft Total loading time: 0 Render date: 2024-05-12T12:04:57.777Z Has data issue: false hasContentIssue false
  • English
  • Français

1041 – The Incidence, Resource Utilization And Financial Costs Of Treating Children With Attention Deficit/hyperactivity Disorder (adhd) In The United Kingdom (uk)

Published online by Cambridge University Press:  15 April 2020

S.E. Holden ,
J. Setyawan ,
D. Coghill ,
P. Hodgkins  and
C.J. Currie
S.E. Holden
Affiliation:
Public Health and Primary Care, School of Medicine, Cardiff University, Cardiff, UK
J. Setyawan
Affiliation:
Global Health Economics & Outcomes Research, Shire Pharmaceuticals LLC, Wayne, PA, USA
D. Coghill
Affiliation:
School of Medicine, University of Dundee, Dundee, UK
P. Hodgkins
Affiliation:
Global Health Economics & Outcomes Research, Shire Pharmaceuticals LLC, Wayne, PA, USA
C.J. Currie
Affiliation:
Public Health and Primary Care, School of Medicine, Cardiff University, Cardiff, UK

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction

ADHD is a common disorder that often presents in childhood and is associated with increased healthcare resource use.

Objectives/aims

To evaluate ADHD incidence and estimate resource utilization and costs of care in the UK.

Methods

The Clinical Practice Research Datalink was searched between 1998 and 2010 for patients aged 6-17 years, newly diagnosed with ADHD. Age- and sex-matched, controls were also identified (ratio 1:3). ADHD incidence was calculated as the number of incident cases/100,000 people (/100k) in the at-risk population. Resource utilization in the first year post-diagnosis was estimated for general practice (GP) contacts, investigations, drug treatments, outpatient appointments, and inpatient admissions. Monetary costs were derived from various sources (at 2011 prices).

Results

2,873 subjects with ADHD and 6,598 matched controls were identified. Mean (standard deviation [SD]) age was 9.8 (2.8) years and most (87%) were boys. The incidence of ADHD amongst boys and girls, respectively, increased from 69/100k and 7/100k in 1998 to 132/100k and 24/100k in 2007, and then fell to 98/100k and 20/100k in 2010. The mean (SD) annual, cost was £1,291 (£2,121) for cases and £315 (£2,345) for controls. For cases and controls, respectively, annual costs comprised GP contacts (£199, £70), investigations (£10, £8), drug treatments (£306, £37), outpatient appointments (£572, £62) and inpatient admissions (£203, £139).

Conclusions

The incidence of ADHD increased between 1998 and 2007, then declined slightly in 2010. Medical costs in the first year post-diagnosis were notably higher in children with ADHD compared with controls

Funding

Shire Development LLC.

Type
Abstract
Information
European Psychiatry , Volume 28 , Issue S1: Abstracts of the 21th European Congress of Psychiatry , 2013 , 28-E453
Copyright
Copyright © European Psychiatric Association 2013
Submit a response

Comments

No Comments have been published for this article.